FDA Clears Six AI-Powered Interventional Imaging Systems from Siemens Healthineers

Geared to interventional radiologists, multiple systems of the Artis vision platform as well as the Artis icono.explore and Artis genio systems have garnered 510(k) clearance from the Food and Drug Administration (FDA).

A unifying feature of these devices is the application of deep learning-based noise reduction with the Optiq AI imaging chain, according to Siemens Healthineers, the manufacturer of the Artis imaging portfolio of devices. The company said the denoising with the Optiq AI imaging chain facilitates enhanced interoperative image quality for interventional radiology procedures.

“As more complex procedures come to interventional labs, increased precision is of paramount importance,” said Kris McVey, head of angiography in the advanced therapies business at Siemens Healthineers North America. “Our new Artis portfolio powered by Optiq AI delivers the high level of image quality clinicians rely upon to guide these intricate procedures—while taking into account the needs and budget of every type of healthcare facility.”

Siemens Healthineers noted that the floor, biplane, ceiling and phenom (floor-mounted robotic) versions of the Artis vision platform provide high speed precision for a variety of image-guided procedures. The floor versions of the Artis icono.explore and Artis genio were designed as workhorse systems capable of handling a broad mix of interventional radiology procedures, according to Siemens Healthineers.